InMode Ltd. NASDAQ:INMD

InMode Ltd. stock price today

$14.3
-2.71
-15.98%
Financial Health
0
1
2
3
4
5
6
7
8
9

InMode Ltd. stock price monthly change

-4.76%
month

InMode Ltd. stock price quarterly change

-4.76%
quarter

InMode Ltd. stock price yearly change

-24.36%
year

InMode Ltd. key metrics

Market Cap
1.44B
Enterprise value
2.79B
P/E
18.28
EV/Sales
6.15
EV/EBITDA
13.59
Price/Sales
6.35
Price/Book
5.20
PEG ratio
-7.92
EPS
2.17
Revenue
466.25M
EBITDA
173.35M
Income
181.11M
Revenue Q/Q
-24.31%
Revenue Y/Y
-1.72%
Profit margin
35.56%
Oper. margin
43.55%
Gross margin
83.82%
EBIT margin
43.55%
EBITDA margin
37.18%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

InMode Ltd. stock price history

InMode Ltd. stock forecast

InMode Ltd. financial statements

Average Price Target
Last Year

$26

Potential upside: 81.81%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

InMode Ltd. (NASDAQ:INMD): Profit margin
Jun 2023 136.08M 55.72M 40.95%
Sep 2023 123.11M 46.52M 37.79%
Dec 2023 126.78M 55.16M 43.51%
Mar 2024 80.28M 23.69M 29.52%
InMode Ltd. (NASDAQ:INMD): Debt to assets
Jun 2023 734084000 67.92M 9.25%
Sep 2023 793530000 70.03M 8.83%
Dec 2023 863286000 75.91M 8.79%
Mar 2024 891735000 76.3M 8.56%
InMode Ltd. (NASDAQ:INMD): Cash Flow
Jun 2023 53M 13.00M 827K
Sep 2023 41.44M -69.82M 2.72M
Dec 2023 61.26M -51.69M 275K
Mar 2024 24.11M -47.39M 234K

InMode Ltd. alternative data

InMode Ltd. Social Media Accounts

What are followers?
InMode Ltd. (NASDAQ:INMD): Followers count
May 2025 104989
Jul 2025 105952
Aug 2025 106385

InMode

InMode Ltd. (NASDAQ:INMD): Google Trends - InMode
21 May 2023 39
28 May 2023 39
4 Jun 2023 33
11 Jun 2023 29
18 Jun 2023 47
25 Jun 2023 28
2 Jul 2023 41
9 Jul 2023 42
16 Jul 2023 38
23 Jul 2023 36
30 Jul 2023 47
6 Aug 2023 31
13 Aug 2023 29
20 Aug 2023 32
27 Aug 2023 37
3 Sep 2023 35
10 Sep 2023 27
17 Sep 2023 29
24 Sep 2023 29
1 Oct 2023 25

Non invasive Treatment

InMode Ltd. (NASDAQ:INMD): Google Trends - Non invasive Treatment
13 Aug 2023 62
20 Aug 2023 53
27 Aug 2023 51
3 Sep 2023 60
10 Sep 2023 55
17 Sep 2023 44
24 Sep 2023 45
1 Oct 2023 57
8 Oct 2023 37
15 Oct 2023 40
22 Oct 2023 34
29 Oct 2023 45
5 Nov 2023 44
12 Nov 2023 36
19 Nov 2023 49
26 Nov 2023 60
3 Dec 2023 52
10 Dec 2023 49
17 Dec 2023 56
24 Dec 2023 49

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

InMode Ltd. (NASDAQ:INMD): Job openings
Aug 2023 10
Sep 2023 13
Oct 2023 8
Nov 2023 2
Dec 2023 4
Jan 2024 1
Feb 2024 0
Apr 2024 1
May 2024 2
Jun 2024 5
Jul 2024 8
Dec 2024 13
Jan 2025 13
Feb 2025 15
May 2025 8
Jul 2025 0
Aug 2025 0
InMode Ltd. (NASDAQ:INMD): Employee count
Aug 2023 480
Sep 2023 480
Oct 2023 480
Nov 2023 480
Dec 2023 480
Jan 2024 480
Feb 2024 480
Mar 2024 581
Apr 2024 581
May 2024 581
Jun 2024 581
Jul 2024 581

InMode Ltd. other data

53.63% -2.66%
of INMD is owned by hedge funds
46.13M -2.28M
shares is hold by hedge funds
Patent
Application
Filling date: 4 Nov 2021 Issue date: 24 Feb 2022
Application
Filling date: 18 Sep 2020 Issue date: 27 Jan 2022
Application
Filling date: 15 Mar 2020 Issue date: 16 Sep 2021
Application
Filling date: 24 May 2021 Issue date: 9 Sep 2021
Application
Filling date: 3 Dec 2020 Issue date: 10 Jun 2021
Application
Filling date: 8 Feb 2021 Issue date: 3 Jun 2021
Application
Filling date: 8 Feb 2021 Issue date: 3 Jun 2021
Application
Filling date: 27 Aug 2020 Issue date: 17 Dec 2020
Application
Filling date: 6 Mar 2020 Issue date: 10 Sep 2020
Application
Filling date: 16 May 2018 Issue date: 21 Nov 2019
Insider Compensation
Mr. Shakil Lakhani (1983) Pres of North America
$2,050,000
Dr. Spero Theodorou M.D. (1972) Chief Medical Officer
$1,620,000
Mr. Yair Malca (1978) Chief Financial Officer
$429,000
Dr. Michael Kreindel (1968) Chief Technology Officer & Director
$217,000
Mr. Moshe Mizrahy (1953) Chairman & Chief Executive Officer
$216,000
Thursday, 12 December 2024
seekingalpha.com
Wednesday, 6 November 2024
prnewswire.com
Tuesday, 5 November 2024
seekingalpha.com
Thursday, 31 October 2024
seekingalpha.com
Wednesday, 30 October 2024
seekingalpha.com
zacks.com
prnewswire.com
Monday, 28 October 2024
accesswire.com
Thursday, 24 October 2024
prnewswire.com
Wednesday, 23 October 2024
zacks.com
Monday, 14 October 2024
zacks.com
Thursday, 10 October 2024
prnewswire.com
Friday, 4 October 2024
seekingalpha.com
Tuesday, 1 October 2024
prnewswire.com
Thursday, 26 September 2024
zacks.com
Thursday, 19 September 2024
seekingalpha.com
Tuesday, 10 September 2024
zacks.com
prnewswire.com
Friday, 6 September 2024
seekingalpha.com
Wednesday, 4 September 2024
prnewswire.com
Tuesday, 6 August 2024
prnewswire.com
Thursday, 1 August 2024
seekingalpha.com
zacks.com
prnewswire.com
Wednesday, 31 July 2024
prnewswire.com
Thursday, 25 July 2024
zacks.com
prnewswire.com
Wednesday, 17 July 2024
prnewswire.com
Thursday, 11 July 2024
prnewswire.com
Monday, 1 July 2024
investorplace.com
  • What's the price of InMode Ltd. stock today?

    One share of InMode Ltd. stock can currently be purchased for approximately $14.3.

  • When is InMode Ltd.'s next earnings date?

    Unfortunately, InMode Ltd.'s (INMD) next earnings date is currently unknown.

  • Does InMode Ltd. pay dividends?

    No, InMode Ltd. does not pay dividends.

  • How much money does InMode Ltd. make?

    InMode Ltd. has a market capitalization of 1.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.32% to 492.05M US dollars.

  • What is InMode Ltd.'s stock symbol?

    InMode Ltd. is traded on the NASDAQ under the ticker symbol "INMD".

  • What is InMode Ltd.'s primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of InMode Ltd.?

    Shares of InMode Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are InMode Ltd.'s key executives?

    InMode Ltd.'s management team includes the following people:

    • Mr. Shakil Lakhani Pres of North America(age: 42, pay: $2,050,000)
    • Dr. Spero Theodorou M.D. Chief Medical Officer(age: 53, pay: $1,620,000)
    • Mr. Yair Malca Chief Financial Officer(age: 47, pay: $429,000)
    • Dr. Michael Kreindel Chief Technology Officer & Director(age: 57, pay: $217,000)
    • Mr. Moshe Mizrahy Chairman & Chief Executive Officer(age: 72, pay: $216,000)
  • How many employees does InMode Ltd. have?

    As Jul 2024, InMode Ltd. employs 581 workers.

  • When InMode Ltd. went public?

    InMode Ltd. is publicly traded company for more then 6 years since IPO on 8 Aug 2019.

  • What is InMode Ltd.'s official website?

    The official website for InMode Ltd. is inmodemd.com.

  • How can i contact InMode Ltd.?

    InMode Ltd. can be reached via phone at +972 4 909 6313.

  • What is InMode Ltd. stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for InMode Ltd. in the last 12 months, the avarage price target is $26. The average price target represents a 81.81% change from the last price of $14.3.

InMode Ltd. company profile:

InMode Ltd.

inmodemd.com
Exchange:

NASDAQ

Full time employees:

581

Industry:

Medical - Devices

Sector:

Healthcare

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Tavor Building
Yokne'am, 2069206

CIK: 0001742692
ISIN: IL0011595993
CUSIP: M5425M103